儿童激素抵抗型局灶节段性肾小球硬化伴感音神经性听力损失中的COQ6突变
在10例激素抵抗型局灶节段性肾小球硬化(SR-FSGS)伴感音神经性听力损失的儿童中,6例检出双等位基因COQ6突变,中位发病年龄29个月,均在起病后中位13个月内进展至终末期肾病,肾活检均见足细胞异常线粒体增生。作者建议对SR-FSGS伴感音神经性听力损失的儿童考虑COQ6突变所致原发性辅酶Q10缺乏,早期诊断并早期补充辅酶Q10可能可治疗。
要点
- SR-FSGS伴感音神经性听力损失的儿童应警惕COQ6突变所致原发性辅酶Q10缺乏。
- 6例COQ6突变患儿中位起病年龄29个月,均在中位13个月内进展至终末期肾病。
- 6例肾活检均见足细胞异常线粒体增生,作者推荐早期肾活检以获取诊断线索。
核心结论
- 儿童同时表现为SR-FSGS和感音神经性听力损失时,应考虑COQ6突变所致原发性辅酶Q10缺乏。
- COQ6突变的早期诊断至关重要,因为早期开始辅酶Q10补充时该病可治疗。
研究设计与样本
- 本报告纳入10例SR-FSGS伴感音神经性听力损失的儿童,其中6例检出双等位基因COQ6突变。
主要发现
- 肾病综合征起病中位年龄为29个月(范围15-47个月)。
- 所有患者均在起病后中位13个月(范围1-27个月)内进展至终末期肾病。
- 肾活检显示6例患者足细胞均存在异常线粒体增生。
- 接受肾移植的5例患者均未出现FSGS复发。
临床怎么用
- 作者建议对SR-FSGS伴感音神经性听力损失的儿童考虑COQ6突变所致原发性辅酶Q10缺乏。
- 作者认为早期诊断COQ6突变至关重要,因早期开始辅酶Q10补充时该病可治疗。
- 作者推荐早期肾活检,因足细胞异常线粒体增生可能提供更早的诊断线索。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The phenotypic combination of steroid-resistant focal segmental glomerulosclerosis (SR-FSGS) and sensorineural hearing loss has been mainly reported in patients with mitochondrial cytopathies, including primary coenzyme Q10 (CoQ10) deficiency. In this report of 10 children with SR-FSGS and sensorineural hearing loss, we found 6 patients with biallelic COQ6 mutations. Median age at the onset of nephrotic syndrome was 29 (range, 15-47) months. All patients progressed to end-stage renal disease within a median of 13 (range, 1-27) months after the onset. Kidney biopsy revealed abnormal mitochondrial proliferation in podocytes in all 6 patients. None of the 5 patients who underwent kidney transplantation developed recurrence of FSGS. Primary CoQ10 deficiency due to COQ6 mutations should be considered in children presenting with both SR-FSGS and sensorineural hearing loss. An early diagnosis of COQ6 mutations is essential because the condition is treatable when CoQ10 supplementation is started at the early stage. We recommend early kidney biopsy because detection of abnormal mitochondrial proliferation in podocytes might provide an earlier diagnostic clue.
引用
- Park E, Ahn YH, Kang HG, et al. COQ6 Mutations in Children With Steroid-Resistant Focal Segmental Glomerulosclerosis and Sensorineural Hearing Loss. Am J Kidney Dis. 2017. PMID: 28117207. doi:10.1053/j.ajkd.2016.10.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。